Taiki Pharmaceutical Private Limited
About Taiki Pharmaceutical Private Limited
Data last updated:
Taiki Pharmaceutical Private Limited is a private limited company based in Roorkee, Uttarakhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U51909UR2021PTC012541. Its GSTIN is 05AAICT6815B1ZK (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harish Chand Singh and Prinshu Singh.
Its last annual general meeting (AGM) was held on 01 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 357/3 29 Civil Line, Roorkee, Uttarakhand, India – 247667.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.06 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹35.97 Lakh (net margin 5.1%) and EBITDA of ₹48.87 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 143% over three years.
As per MCA filings, the company has open charges of ₹60 Lakh on record.
Company details
Contact details
Taiki Pharmaceutical Private Limited's registered office is in Roorkee, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered Address357/3 29 Civil Line, Roorkee, Uttarakhand, India – 247667
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Taiki Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Taiki Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Taiki Pharmaceutical Private Limited, buy the company report.
Financials of Taiki Pharmaceutical Private Limited
FY 2025 filings availableTaiki Pharmaceutical Private Limited reported revenue of ₹7.06 Cr (up 218% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 143% over three years, including 218% growth in the latest year. EBITDA rose 182% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹48.87 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹35.97 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.9% | |||
| Net Profit Margin | 5.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Taiki Pharmaceutical Private Limited, buy the company report.
Board of directors of Taiki Pharmaceutical Private Limited
Taiki Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Chand Singh | Director | 22 Jun 2021 | 5 Years 4 Months | Current |
| Prinshu Singh | Director | 22 Jun 2021 | 5 Years 4 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Aug 2025 | 101159901 | Hdfc Bank Limited | ₹60 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Taiki Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Taiki Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Taiki Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAICT6815B1ZK | Uttarakhand | Active | 22 Jun 2021 |
To see the full GST registrations and return filing status of Taiki Pharmaceutical Private Limited, buy the company report.
Recent activity
Taiki Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Harish Chand Singh was appointed as Director on 22 Jun 2021.
Frequently asked questions
Taiki Pharmaceutical is an active private limited company based in Roorkee, Uttarakhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 June 2021 (5+ years old) and is registered under CIN U51909UR2021PTC012541.
Taiki Pharmaceutical has 2 current directors:
- Harish Chand Singh - Director
- Prinshu Singh - Director
The latest financial statements of Taiki Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 01 August 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Taiki Pharmaceutical is 05AAICT6815B1ZK, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Taiki Pharmaceutical is U51909UR2021PTC012541. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Taiki Pharmaceutical was incorporated on 22 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttarakhand.
Harish Chand Singh was appointed as Director on 22 Jun 2021. Prinshu Singh was appointed as Director on 22 Jun 2021.
The registered office of Taiki Pharmaceutical is at 3573 29 Civil Line, Roorkee, Uttarakhand, India – 247667.
Taiki Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Taiki Pharmaceutical has open charges of ₹60 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
